These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9231347)

  • 1. Saturable urinary excretion kinetics of famotidine in the dog.
    Boom SP; Hoet S; Russel FG
    J Pharm Pharmacol; 1997 Mar; 49(3):288-92. PubMed ID: 9231347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man.
    Lin JH; Chremos AN; Yeh KC; Antonello J; Hessey GA
    Eur J Clin Pharmacol; 1988; 34(1):41-6. PubMed ID: 2896129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysaccharide in rats.
    Hasegawa T; Nadai M; Wang L; Takayama Y; Kato K; Nabeshima T; Kato N
    Drug Metab Dispos; 1994; 22(1):8-13. PubMed ID: 8149895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of famotidine in patients with cystic fibrosis.
    Maish WA; McCubbin MM; Letzig LG; Farrar HC; Kearns GL
    J Clin Pharmacol; 1998 Nov; 38(11):1010-6. PubMed ID: 9824781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tubular functional capacity in humans using para-aminohippurate and famotidine.
    Dowling TC; Frye RF; Fraley DS; Matzke GR
    Kidney Int; 2001 Jan; 59(1):295-303. PubMed ID: 11135083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion kinetics of famotidine in rats.
    Lin JH; Los LE; Ulm EH; Duggan DE
    Drug Metab Dispos; 1987; 15(2):212-6. PubMed ID: 2882981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers.
    Inotsume N; Nishimura M; Nakano M; Fujiyama S; Sato T
    J Clin Pharmacol; 1990 Jan; 30(1):50-6. PubMed ID: 2303581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of famotidine in children.
    James LP; Marshall JD; Heulitt MJ; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure.
    Hachisu T; Yokoyama T; Oda Y; Ando K; Hattori Y; Yoshida T
    Clin Ther; 1988; 10(6):656-63. PubMed ID: 2905936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists.
    Tahara H; Kusuhara H; Chida M; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1187-94. PubMed ID: 16291876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.
    Klotz U; Arvela P; Rosenkranz B
    Eur J Clin Pharmacol; 1985; 28(6):671-5. PubMed ID: 2866097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Floating controlled drug delivery system of famotidine loaded hollow microspheres (microballoons) in the stomach.
    Ramachandran S; Shaheedha SM; Thirumurugan G; Dhanaraju MD
    Curr Drug Deliv; 2010 Jan; 7(1):93-7. PubMed ID: 20044907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A physiologically based kidney model for the renal clearance of ranitidine and the interaction with cimetidine and probenecid in the dog.
    Boom SP; Meyer I; Wouterse AC; Russel FG
    Biopharm Drug Dispos; 1998 Apr; 19(3):199-208. PubMed ID: 9570004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal interaction between itraconazole and cimetidine.
    Karyekar CS; Eddington ND; Briglia A; Gubbins PO; Dowling TC
    J Clin Pharmacol; 2004 Aug; 44(8):919-27. PubMed ID: 15286096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and efficacy of intravenous famotidine in adult cattle.
    Balcomb CC; Heller MC; Chigerwe M; Knych HK; Meyer AM
    J Vet Intern Med; 2018 May; 32(3):1283-1289. PubMed ID: 29572958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.
    Inotsume N; Nishimura M; Fujiyama S; Sagara K; Sato T; Imai Y; Matsui H; Nakano M
    Eur J Clin Pharmacol; 1989; 36(5):517-20. PubMed ID: 2568929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.
    James LP; Kearns GL
    Clin Pharmacokinet; 1996 Aug; 31(2):103-10. PubMed ID: 8853932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of famotidine.
    Echizen H; Ishizaki T
    Clin Pharmacokinet; 1991 Sep; 21(3):178-94. PubMed ID: 1764869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tubular excretion of the N4-acetyl metabolites of sulphasomidine and sulphadimethoxine in the dog.
    Boom SP; Wouterse AC; Vree TB; Van Ginneken CA; Russel FG
    J Pharm Pharmacol; 1993 Jul; 45(7):614-7. PubMed ID: 8105055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.